Total Payments
$23,023
2024 Payments
$11,149
Companies
36
Transactions
178
Medicare Patients
8,548
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$7,891 (34.3%)
Consulting$6,600 (28.7%)
Food & Beverage$5,680 (24.7%)
Travel$2,754 (12.0%)
Education$97.98 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,600 | 7 | 28.7% |
| Current or prospective ownership or investment interest | $5,891 | 2 | 25.6% |
| Food and Beverage | $5,680 | 148 | 24.7% |
| Travel and Lodging | $2,754 | 11 | 12.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000 | 1 | 8.7% |
| Education | $97.98 | 5 | 0.4% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$23,023
174 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BLUEWIND MEDICAL | $6,854 | 13 | $0 (2024) |
| Innovative Medical Technologies, LLC | $5,891 | 6 | $0 (2020) |
| Medtronic, Inc. | $3,521 | 27 | $0 (2024) |
| Teleflex LLC | $1,246 | 11 | $0 (2024) |
| NeoTract Inc. | $1,151 | 9 | $0 (2020) |
| PROCEPT BioRobotics Corporation | $1,108 | 11 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $632.29 | 10 | $0 (2024) |
| Endo USA, Inc. | $467.50 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $434.24 | 22 | $0 (2023) |
| Axonics, Inc. | $307.44 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,149 | 53 | BLUEWIND MEDICAL ($6,854) |
| 2023 | $2,642 | 45 | Teleflex LLC ($1,113) |
| 2022 | $647.20 | 18 | Medtronic, Inc. ($258.18) |
| 2021 | $670.45 | 15 | Medtronic, Inc. ($370.66) |
| 2020 | $421.64 | 7 | PROCEPT BioRobotics Corporation ($367.80) |
| 2019 | $414.44 | 16 | Astellas Pharma US Inc ($165.05) |
| 2018 | $1,077 | 14 | NeoTract Inc. ($991.49) |
| 2017 | $6,001 | 10 | Innovative Medical Technologies, LLC ($5,891) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $126.63 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: HORMONE THERAPY | ||||||
| 12/10/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/04/2024 | BLUEWIND MEDICAL | REVI (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: BLADDER | ||||||
| 11/22/2024 | Medtronic, Inc. | INTERSTIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/07/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $140.93 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $129.71 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $121.68 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $58.66 | General |
| Category: UROLOGY | ||||||
| 10/04/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: HORMONE THERAPY | ||||||
| 09/19/2024 | BLUEWIND MEDICAL | REVI (Device) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: BLADDER | ||||||
| 09/19/2024 | BLUEWIND MEDICAL | REVI (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: BLADDER | ||||||
| 09/18/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: BLADDER | ||||||
| 09/17/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $67.19 | General |
| Category: BLADDER | ||||||
| 09/09/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/05/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $111.70 | General |
| Category: UROLOGY | ||||||
| 09/03/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $199.94 | General |
| Category: UROLOGY | ||||||
| 09/01/2024 | BLUEWIND MEDICAL | REVI (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: BLADDER | ||||||
| 09/01/2024 | BLUEWIND MEDICAL | REVI (Device) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: BLADDER | ||||||
| 08/29/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $150.16 | General |
| Category: Urology | ||||||
| 08/26/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/06/2024 | BLUEWIND MEDICAL | REVI (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: BLADDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,664 | 2,635 | $492,075 | $199,943 |
| 2022 | 35 | 2,206 | 4,872 | $659,685 | $291,693 |
| 2021 | 33 | 2,867 | 7,584 | $910,663 | $447,167 |
| 2020 | 32 | 1,811 | 2,994 | $495,942 | $242,232 |
Total Patients
8,548
Total Services
18,085
Medicare Billing
$1.2M
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 590 | $95,580 | $51,655 | 54.0% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Office | 2023 | 14 | 53 | $74,624 | $33,693 | 45.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 112 | 128 | $54,656 | $19,282 | 35.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 109 | $34,662 | $14,588 | 42.1% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Office | 2023 | 14 | 14 | $27,230 | $13,115 | 48.2% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Office | 2023 | 14 | 14 | $48,672 | $11,070 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $23,406 | $10,033 | 42.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 62 | 72 | $26,457 | $9,798 | 37.0% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 39 | 55 | $13,048 | $7,317 | 56.1% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $12,573 | $5,964 | 47.4% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Facility | 2023 | 12 | 13 | $8,281 | $3,031 | 36.6% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 33 | 41 | $10,167 | $2,874 | 28.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 211 | 301 | $9,632 | $2,236 | 23.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 326 | 595 | $7,140 | $2,016 | 28.2% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 17 | 92 | $5,612 | $1,993 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 32 | $3,520 | $1,914 | 54.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 19 | 19 | $4,389 | $1,844 | 42.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 14 | 31 | $2,976 | $1,334 | 44.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 11 | 11 | $2,255 | $1,093 | 48.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 97 | 129 | $1,290 | $1,084 | 84.0% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 23 | 31 | $7,208 | $853.31 | 11.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $1,716 | $705.54 | 41.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 30 | $960.00 | $515.40 | 53.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 14 | $840.00 | $507.21 | 60.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 18 | $990.00 | $449.82 | 45.4% |
About Eric Espinosa
Eric Espinosa is a Urology healthcare provider based in Springfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265405914.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Espinosa has received a total of $23,023 in payments from pharmaceutical and medical device companies, with $11,149 received in 2024. These payments were reported across 178 transactions from 36 companies. The most common payment nature is "Consulting Fee" ($6,600).
As a Medicare-enrolled provider, Espinosa has provided services to 8,548 Medicare beneficiaries, totaling 18,085 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Springfield, OH
- Active Since 02/10/2006
- Last Updated 01/05/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1265405914
Products in Payments
- REVI (Device) $6,854
- INTERSTIM (Device) $3,043
- UROLIFT (Device) $2,021
- PROVENGE (Drug) $632.29
- XIAFLEX (Biological) $563.79
- AquaBeam Robotic System (Device) $385.60
- AQUABEAM ROBOTIC SYSTEM (Device) $364.14
- AQUABEAM SYSTEM (Device) $358.14
- Axonics (Device) $307.44
- UroLift (Device) $287.35
- Dornier MedTech (Device) $208.44
- XTANDI (Drug) $184.10
- Optilume BPH Drug Coated Balloon Catheter (Device) $143.53
- GEMTESA (Drug) $125.79
- BOTOX (Biological) $117.62
- MYRBETRIQ (Drug) $112.25
- JELMYTO (Drug) $97.76
- Myrbetriq (Drug) $91.78
- UroLift System (Device) $88.66
- ORGOVYX (Drug) $75.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Springfield
Bryan Mehlhaff, Md, MD
Urology — Payments: $1.5M
Urology $1.5M
Kevin Mcvary, Md, MD
Urology — Payments: $405,504
Urology $405,504
Bradley Schwartz, M.d, M.D
Urology — Payments: $105,537
Urology $105,537
Robert Nadler, Md, MD
Urology — Payments: $93,691
Urology $93,691
Kevin Krughoff
Urology — Payments: $54,104
Urology $54,104
Michael Zavaski, Md, MD
Urology — Payments: $22,511
Urology $22,511